Literature DB >> 3300538

Sub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae.

P Williams.   

Abstract

Growth of encapsulated (K+) and nonencapsulated (K-) Klebsiella pneumoniae strains in media containing sub-MICs of either cefuroxime or ciprofloxacin resulted in cell elongation but had little effect on the outer membrane protein or lipopolysaccharide profiles. Exposure to serum complement increased the surface hydrophobicity of a K- strain but failed to interact or to increase the surface hydrophobicity of the K+ strains. However, after growth of the K+ strains in sub-MICs of the antibiotics, complement increased their surface hydrophobicity and complement C3 was detected bound to their surface. Antisera raised against a K-O- strain agglutinated the K+ strains grown in the presence but not in the absence of cefuroxime or ciprofloxacin. These findings suggest that the filamentous morphology induced by these antibiotics influences the distribution or amount of capsular polysaccharide such that cell envelope components previously masked by the capsule become accessible to complement and immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300538      PMCID: PMC174828          DOI: 10.1128/AAC.31.5.758

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  The influence of the O and K antigens of Klebsiella aerogenes on surface hydrophobicity and susceptibility to phagocytosis and antimicrobial agents.

Authors:  P Williams; P A Lambert; C G Haigh; M R Brown
Journal:  J Med Microbiol       Date:  1986-03       Impact factor: 2.472

2.  Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands.

Authors:  B Lugtenberg; J Meijers; R Peters; P van der Hoek; L van Alphen
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

3.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

4.  Combined biochemical and serological typing of clinical isolates of Klebsiella.

Authors:  R P Rennie; I B Duncan
Journal:  Appl Microbiol       Date:  1974-10

Review 5.  Antibiotics and phagocytosis.

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

6.  Effect of iron deprivation on the production of siderophores and outer membrane proteins in Klebsiella aerogenes.

Authors:  P Williams; M R Brown; P A Lambert
Journal:  J Gen Microbiol       Date:  1984-09

7.  The role of K antigens as virulence factors in Klebsiella.

Authors:  A M Simoons-Smit; A M Verweij-van Vught; D M MacLaren
Journal:  J Med Microbiol       Date:  1986-03       Impact factor: 2.472

Review 8.  Progress in immunization against Klebsiella infections.

Authors:  S J Cryz
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

9.  Influence of ciprofloxacin on the ultrastructure of gram-negative and gram-positive bacteria.

Authors:  W H Voigt; H J Zeiler
Journal:  Arzneimittelforschung       Date:  1985

10.  Effect of subinhibitory concentrations of cephalosporins on surface properties and siderophore production in iron-depleted Klebsiella pneumoniae.

Authors:  J L Kadurugamuwa; H Anwar; M R Brown; O Zak
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

View more
  12 in total

1.  Antibacterial and immunostimulatory properties of chemotactic N-formyl peptide conjugates of ampicillin and amoxicillin.

Authors:  B W Bycroft; P M Lockey; A Penrose; R J Grout; P Williams
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface.

Authors:  G Raponi; N Keller; B P Overbeek; M Rozenberg-Arska; K P van Kessel; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

3.  Effects of MICs and sub-MICs of antibiotics on production of capsular polysaccharide of Klebsiella pneumoniae.

Authors:  T K Held; C Adamczik; M Trautmann; A S Cross
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

4.  Alterations in surface hydrophobicity of Acinetobacter baumannii induced by meropenem.

Authors:  A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

5.  Binding to and opsonophagocytic activity of O-antigen-specific monoclonal antibodies against encapsulated and nonencapsulated Klebsiella pneumoniae serotype O1 strains.

Authors:  T K Held; N R Jendrike; T Rukavina; R Podschun; M Trautmann
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence.

Authors:  M Bonnet; P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

7.  Routes of quinolone permeation in Escherichia coli.

Authors:  J S Chapman; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

Review 8.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 9.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

10.  Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains.

Authors:  Elisa Ramos-Sevillano; Cinthya Rodríguez-Sosa; Fabio Cafini; Maria-Jose Giménez; Ana Navarro; David Sevillano; Luis Alou; Ernesto García; Lorenzo Aguilar; Jose Yuste
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.